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CTLA-4 and CD4CD25 Regulatory T Cells Inhibit
Protective Immunity to Filarial Parasites In Vivo1
Matthew D. Taylor,2* Anjanette Harris, Simon A. Babayan, Odile Bain,† Abigail Culshaw,
Judith E. Allen, and Rick M. Maizels
The T cell coinhibitory receptor CTLA-4 has been implicated in the down-regulation of T cell function that is a quintessential feature
of chronic human filarial infections. In a laboratory model of filariasis, Litomosoides sigmodontis infection of susceptible BALB/c mice,
we have previously shown that susceptibility is linked both to a CD4CD25 regulatory T (Treg) cell response, and to the development
of hyporesponsive CD4 T cells at the infection site, the pleural cavity. We now provide evidence that L. sigmodontis infection drives
the proliferation and activation of CD4Foxp3 Treg cells in vivo, demonstrated by increased uptake of BrdU and increased expression
of CTLA-4, Foxp3, GITR, and CD25 compared with naive controls. The greatest increases in CTLA-4 expression were, however, seen
in the CD4Foxp3 effector T cell population which contained 78% of all CD4CTLA-4 cells in the pleural cavity. Depletion of CD25
cells from the pleural CD4 T cell population did not increase their Ag-specific proliferative response in vitro, suggesting that their
hyporesponsive phenotype is not directly mediated by CD4CD25 Treg cells. Once infection had established, killing of adult parasites
could be enhanced by neutralization of CTLA-4 in vivo, but only if performed in combination with the depletion of CD25 Treg cells.
This work suggests that during filarial infection CTLA-4 coinhibition and CD4CD25 Treg cells form complementary components of
immune regulation that inhibit protective immunity in vivo. The Journal of Immunology, 2007, 179: 4626–4634.
D own-regulation of T cell function resulting in immunesuppression is a quintessential feature of chronic helminthinfections (1–7). In human filariasis, immunosuppression is
characterized by the impairment of both Ag-specific Th1 and Th2
immune responses (8–10). Filarial parasites suppress host immunity
through a variety of immunoregulatory layers involving T cells, mac-
rophages, and dendritic cells (DC)3 (6, 11–15). Of these layers, reg-
ulation within the CD4 T cell compartment plays a vital role in
determining the outcome of infection (16), combining the induction of
regulatory T (Treg) cell responses (10, 16, 17) and the development of
intrinsically hyporesponsive or “conditioned” effector T (Teff) cells
(10, 16). The observations that the T cell inhibitory receptor CTLA-4,
linked with both CD4 Treg cell responses and Teff cell tolerance
(18, 19), plays an in vitro role in filarial-induced suppression in hu-
mans has led to the hypothesis that it is an important element in
controlling susceptibility to filariasis (10, 20).
CTLA-4 is a potent inhibitor of T cells and is involved in mediating
T cell anergy and tolerance (18, 19). A consequence of its importance
is illustrated by CTLA-4-deficient mice that die of lymphoprolifera-
tive disease within 3–4 wk of age (21, 22). CTLA-4 is constitutively
expressed by CD25Foxp3 Treg cells (23, 24) and is up-regulated
by CD4 Teff cells following antigenic stimulation. CTLA-4 can sup-
press immunity through a surprisingly diverse range of mechanisms,
the most direct of which are competition with the positive costimu-
latory molecule CD28 for common ligands, along with transmission
of a cell-intrinsic negative signal that inhibits T cell activation
(25–27). One effect of signaling through CTLA-4 may be to ab-
breviate the dwell time between T cell and APC; therefore, further
reducing the strength of TCR-mediated stimulation (28). Indirect
mechanisms include stimulating the production of the regulatory
cytokine TGF- (29–31) and “back signaling” through CD80/
CD86, causing up-regulation of indoleamine 2,3-dioxygenase re-
sulting in the development of DC with inhibitory properties (32,
33). Although many of the regulatory roles of CTLA-4 are inde-
pendent of and can be complementary to Treg cells (34, 35),
CTLA-4 is also associated with the development and suppressive
function of Treg cell responses (23, 24, 36, 37).
The inhibitory effects of CTLA-4 impede immunity to a variety
of different infections (38–41). CTLA-4 is believed to preferen-
tially modify Th2 responses (42) and has been shown to down-
regulate Th2 immune responses to helminth infections, such that
neutralizing CTLA-4 during Nippostrongylus brasiliensis infec-
tion enhances protective immunity (43). Inhibition through
CTLA-4, therefore, makes a strong candidate for a mechanism of
filarial immunosuppression. In both human filariasis and in murine
infection models, expression of CTLA-4 by CD4 T cells is up-
regulated upon infection (10, 16, 20) and is linked to CD4CD25
Treg and Tr1 cell responses (16, 17, 20, 44). In humans, CTLA-4
has been shown to play a role in the in vitro Ag unresponsiveness
of PBMC, but rather than acting through CD4 Treg cells,
CTLA-4 appears to mediate inhibition by inducing the expression
of T cell anergy factors (10, 20). Similar observations have been
noted during Helicobacter pylori infection, in which T cell unre-
sponsiveness was due to CTLA-4 mediated T cell anergy rather
than active suppression through CD4CD25 Treg cells (41).
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Using the model filarial nematode Litomosoides sigmodontis
(45, 46), we have previously shown that CD4 T cell regulation is
a major determinant of susceptibility to L. sigmodontis infection
(16), allowing the development of patent infections in BALB/c
mice. Patency is defined by the appearance of transmission stage
microfilariae (Mf) in the bloodstream 55 days after infection.
CD4 T cell regulation was denoted by a CD4CD25Foxp3
Treg cell response and a loss of CD4 T cell Ag-responsiveness at
the site of infection (the pleural cavity) between 40 and 60 days
after infection (16). Despite a role for CD4CD25 Tregs in in-
hibiting protective immunity to L. sigmodontis, the loss of CD4
T cell Ag responsiveness was not associated with increased ex-
pression of Foxp3 mRNA, but was associated with dramatically
up-regulated expression of the coinhibitory receptor CTLA-4 and
the costimulatory molecule GITR. Simultaneously depleting
CD25 Treg cells along with providing costimulatory signals
through GITR restored T cell Ag responsiveness and resulted in
enhanced killing of an established infection. These results led to
our hypothesis that L. sigmodontis infection induces two distinct
levels of T cell regulation, conventional CD4Foxp3CD25
Tregs and the development of a newly recognized intrinsically
hyporesponsive phenotype within the CD4CTLA-4GITRhigh
Teff cells (16). The Ag responsiveness of the CD4 Teff cells is
controlled by the balance of signals received through their co-
stimulatory and coinhibitory receptors.
We now demonstrate that CTLA-4 complements CD25 Treg
cells in inhibiting protective immunity to filarial infection in vivo.
We show that L. sigmodontis infection drove the proliferation and
activation of CD4Foxp3 Treg cells, but provide evidence that
CD4 Teff cell hyporesponsiveness was not due to active suppres-
sion by CD4CD25 Treg cells. Although infection up-regulated
the expression of CTLA-4 on CD4Foxp3 Treg cells, the great-
est increase in CTLA-4 expression was seen on the CD4Foxp3
Teff cells, suggesting that CTLA-4 is directly inhibiting CD4
Teff cells. Once infection had established, parasite killing could
only be enhanced by simultaneously targeting both levels of T cell
regulation: blockade of inhibitory signals through CTLA-4 in com-
bination with CD25 Treg cell depletion.
Materials and Methods
Mice and parasites
Female BALB/c mice were used at 6–8 wk of age and maintained in
individually ventilated cages. The L. sigmodontis life cycle was maintained
in gerbils using the mite vector Ornithonyssus bacoti (46). Infective larvae
(L3) were recovered from mites 13 days postfeeding by dissection in RPMI
1640 supplemented with 10% FBS (Invitrogen Life Technologies), and
mice were infected s.c. on the upper back. Pleural lavage with 10 ml of cold
AIM V medium was used to recover parasites. Recovered parasites were
fixed in hot 70% ethanol for detailed morphological analysis including
length, uterine contents, developmental state, and physiological condition
(46). L. sigmodontis whole worm Ag (LsAg) was prepared by collecting
the PBS-soluble fraction of homogenized adult male and female worms.
In vivo Ab and BrdU treatments
In vivo Ab treatments utilized anti-CTLA-4 (UC10-4F10-11) and anti-
CD25 (PC61). Mice received either 1 mg of anti-CTLA-4 in PBS on days
27 and 32 alone or in combination with 1 mg of anti-CD25 on day 27. An
equivalent dose of rat IgG was used as a control. For BrdU treatment, mice
received i.p. injections of 0.8 mg of BrdU (Sigma-Aldrich) in PBS 24
and 16 h before autopsy.
Cell purifications and in vitro restimulations
The parathymic, posterior mediastinal, and paravertebral lymph nodes
draining the thoracic cavity (tLN) were dissociated and washed in AIM V
medium before being resuspended in RPMI 1640 with 0.5% mouse sera
(Caltag Laboratories-Medsystems), 100 U/ml penicillin/100 g/ml strep-
tomycin, and 2 mM L-glutamine. Pleural cavity cells (PleC) were isolated
from lavage fluid. For CD4 and CD4CD25 T cell purifications, PleC
were adhered to plastic for 2 h at 37° and the nonadherent population was
taken. CD4 purifications were performed using CD4 MicroBead magnetic
cell sorting (Miltenyi Biotec) per the manufacturer’s instructions, except
that HBSS/0.25% mouse serum was used as the separation medium and 15
g of rat IgG/1  107 cells was used as a block. To purify CD4CD25
T cells, CD25 depletion was performed before the CD4 purification using
biotinylated anti-CD25 (PC61; BD Pharmingen) in combination with
streptavidin MicroBead magnetic sorting (Miltenyi Biotec). CD4 T cell
purities were 75.1–81.2% with 41.5–47% of the CD4 T cells from in-
fected mice expressing CD25. CD4CD25 T cell purifications contained
85.2–89.2% CD4 T cells, of which 12–22% expressed low levels of
CD25. Irradiated (30 Gy) splenic APC were added to 96-well round-bot-
tom plates at 1  106 cells/well, along with 1  105 CD4 T cells/well.
Whole tLN cells were used at 5  105 cells/well. Cultures were stimulated
with medium alone or 10 g/ml LsAg. Supernatants were sampled at 72 h
for cytokine analysis, and 1 Ci/well [methyl-3H]thymidine was added for
16 h to measure proliferation.
Abs and reagents
Ab pairs used for cytokine ELISAs were: IL-4 (11B11/BVD6-24G2), IL-5
(TRFK5/TRFK4), IL-10 (JES5-2A5/SXC-1), and IFN- (R4-6A2/
XMG1.2). Recombinant murine IL-4, IFN-, IL-10, and IL-5 (Sigma-
Aldrich) were used as cytokine standards. Biotin detection Abs were used
with ExtrAvidin/alkaline phosphatase conjugate (Sigma-Aldrich) and Sig-
ma-Aldrich FastTM p-nitrophenyl phosphate substrate. For flow cytometry
(FC), nonspecific binding was blocked with 4 g of rat IgG/1  106 cells
and the following Abs applied: PE-conjugated anti-CTLA-4 (UC10-4F10-
11), peridinin chlorophyll protein-conjugated streptavidin, allophycocya-
nin and FITC-conjugated anti-CD4 (RM4-5), biotinylated anti-CD25
(7D4), and FITC-conjugated anti-GITR (DTA-1, in house). Staining for
Foxp3 was performed using FITC-, PE-, and allophycocyanin-conjugated
anti-Foxp3 (FJK-16s; eBioscience) per the manufacturer’s instructions.
BrdU staining was performed after the final Foxp3 staining step using
FITC-conjugated anti-BrdU with DNase according to the manufacturer’s
instructions (BD Pharmingen). Staining was compared against the relevant
isotype controls to verify specificity. Because the majority of CD4 T cells
expressed low levels of GITR when compared with the isotype control, FC
plots were gated on CD4GITRhigh cells. To measure intracellular
CTLA-4, cells were permeabilized with a BD Pharmingen Cytofix/Cyto-
perm kit or with a eBioscience Foxp3 permeabilization kit. Flow cytomet-
ric acquisition was performed using a FACSCalibur running CellQuest Pro
software and a LSR 2 running FACSDiva software (BD Biosciences).
Analysis was performed using CellQuest Pro and FlowJo (Tree star). Re-
agents were obtained from BD Biosciences unless otherwise stated.
L. sigmodontis-specific Ab ELISA
Serum was isolated from whole blood using SeraSieve (Hughes and
Hughes). ELISA plates (Nunc) were coated with LsAg at a concentration
of 5 g/ml in 0.45 M NaHCO3 (Sigma-Aldrich)/0.18 M Na2CO3 (Sigma-
Aldrich). Plates were incubated with eight serial dilutions (1/200–1/25600)
of mouse sera, and a representative dilution from the linear section of the
dilution curve was selected for each isotype (1/800 for IgG1 and 1/200
for IgG2a and IgG2b). Detection of Ab isotypes was performed using
HRP-conjugated anti-mouse IgG1, IgG2a, and IgG2b (Southern Bio-
technology Associates) in combination with an ABTS peroxidase sub-
strate system (KPL).
Statistics
Statistical analysis was performed using JMP version 6 (SAS). Analysis of
combined data from multiple repeat experiments, or of experiments con-
taining multiple groups, was performed using one-way or general linear
model (GLM) ANOVA. When using GLM to combine data from multiple
experiments, it was first verified that there were no significant differences
between experiments before treatment effects were analyzed. Pairwise
comparison between means was performed using the Wilcoxon rank test.
Results
CD4Foxp3 Treg cells actively respond to L. sigmodontis
infection, but are not directly associated with the in vitro CD4
T cell hyporesponsiveness
Our previous work led to the hypothesis that L. sigmodontis in-
fection induces two distinct components of T cell regulation within
the pleural cavity: suppressive CD4CD25 Tregs and intrinsi-
cally hyporesponsive CD4CTLA-4GITRhigh Teff cells. To test
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whether the latter subset represents a Foxp nonregulatory cell
population, we stained the pleural cavity CD4 (pleCD4) T cells
from naive and L. sigmodontis-infected BALB/c mice 60 days
postinfection for intracellular Foxp3 and CTLA-4 and surface
CD25 and GITR. In confirmation of our previous results, 50–70%
of the pleCD4 T cell population from infected mice coexpressed
high levels of CTLA-4 and GITR (Fig. 1, A and E). The pleCD4
T cells from infected mice also showed higher forward scatter and
side scatter profiles than those from naive mice, indicative of a
blasting phenotype (data not shown). Costaining for Foxp3 dem-
onstrated that the majority of CD4CTLA-4GITRhigh cells were
Foxp3 and thus appear to represent an activated CD4 Teff cell
population rather than a CD4Foxp3 Treg cell population
(CTLA-4; Fig. 1, B and F; GITR, Fig. 1, C and G). Overall, in
infection the majority of CD4CD25 T cells were also Foxp3
(Fig. 1, D and H). In fact, although there was a significant expan-
sion in the absolute numbers of CD4Foxp3 Tregs in the pleural
cavity 60 days after infection (Fig. 1I), their proportion within the
CD4 T cell population was significantly decreased compared
with naive mice (Fig. 1J).
Since total numbers of pleCD4Foxp3 Treg cells were in-
creased, we tested whether infection was driving their expansion
by using BrdU incorporation to assess the proliferation of different
pleCD4 T cell subsets in vivo. Naive and infected mice were
injected with BrdU on day 59 of infection and 24 h later ex vivo
FC was used to assess BrdU uptake by Foxp3 and Foxp3CD4
T cells. In both the naive and infected mice, the CD4Foxp3
Treg population contained a significantly higher percentage of di-
vided cells compared with the CD4Foxp3 Teff population, in-
dicating that the CD4Foxp3 Treg cells generally show a higher
FIGURE 1. The majority of pleCD4CTLA-4GITRhigh T cells do not express Foxp3. PleC from naive and L. sigmodontis- infected BALB/c mice
were isolated 60 days postinfection and FC was used to analyze the expression of Foxp3, CD25, GITR, and CTLA-4 within the CD4 T cell
population. A–D, Dot plots, gated on CD4 T cells, demonstrating expression of GITR vs CTLA-4 (A), Foxp3 vs CTLA-4 (B), Foxp3 vs GITR (C),
and Foxp3 vs CD25 (D). Experiments were performed at least twice with four to six mice per group; data are from one representative mouse per
group. E, Percentage of pleCD4 T cells from naive (E) and 60-day infected mice (F) coexpressing high levels of CTLA-4 and GITR. Symbols
represent individual animals, and the line represents the median (, p  0.05; Wilcoxon rank test). Results are representative of eight independent
experiments. F, Percentage of CTLA-4Foxp3 and CTLA-4Foxp3 cells within the pleCD4 T cell population from naive (E) and 60-day
infected mice (F). Symbols represent individual animals, and the line represents the median (, p  0.05; Wilcoxon rank test). Results are
representative of two independent experiments. G, Percentage of GITRhighFoxp3 and GITRhighFoxp3 cells within the pleCD4 T cell population
from naive (E) and 60-day infected mice (F). Symbols represent individual animals, and the line represents the median (, p  0.05; Wilcoxon rank
test). Results are representative of two independent experiments. H, Percentage of CD25Foxp3 and CD25Foxp3 cells within the pleCD4 T
cell population from naive (E) and 60-day infected mice (F). Symbols represent individual animals, and the line represents the median (, p  0.05;
Wilcoxon rank test). Results are representative of three independent experiments. I, Total number of CD4Foxp3 T cells within the pleural cavity
of naive (E) and infected (F) BALB/c mice 60 days postinfection. Shown are combined data from six separate experiments, with symbols
representing individual mice and the line representing the mean value (, p  0.01; GLM). J, Percentage of CD4 T cells expressing Foxp3 within
the pleural cavity of naive (E) and infected (F) BALB/c mice 60 days postinfection. Shown are combined data from six separate experiments, with
symbols representing individual mice and the line representing the mean value (, p  0.01; GLM).
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rate of cell division in vivo (Fig. 2A). Infection did drive the pro-
liferation of CD4Foxp3 Treg cells because there was a signif-
icant 2-fold increase in the percentage of dividing CD4Foxp3
Treg cells compared with naive mice. The CD4Foxp3 Teff cells
from infected mice also showed significantly higher levels of pro-
liferation in vivo with a 6-fold increase over the naive controls.
Alongside the increased proliferative response, the CD4
Foxp3 Tregs from infected mice showed a more activated phe-
notype than those from naive mice, with significantly increased
levels of expression of Foxp3, CD25, GITR, and CTLA-4 over the
naive controls (Fig. 2B). Given the activated phenotype of the
CD4Foxp3CD25 Treg cells, we tested whether they were in-
hibiting the Ag-specific responsiveness of the pleCD4 T cell pop-
ulation. CD4 T cells and CD4CD25 T cells were purified from
the pleural cavity 60 days after infection and their ability to res-
pond to LsAg in the presence of irradiated spleen cells from naive
animals was compared in vitro. Depleting the CD4CD25 T
cells from the whole CD4 T cell population did not increase their
Ag-specific proliferative responses (Fig. 2C). Thus, infection with
L. sigmodontis drives the activation and proliferation of CD4
Foxp3CD25 Treg cells; however, the CD4Foxp3CD25
Treg cells do not appear to be responsible for the previously doc-
umented loss of in vitro Ag responsiveness of the pleCD4 T cells
(16) since their depletion did not increase Ag-specific proliferation.
In vivo neutralization of CTLA-4 enhances parasite killing when
combined with the depletion of CD25 Treg cells
The high expression of intracellular CTLA-4 by the pleCD4
Foxp3 Teff cells and the pleCD4Foxp3 Treg cells suggests a
role for CTLA-4 in suppressing T cell responses during L. sigmo-
dontis infection. To directly test whether CTLA-4 is acting to in-
hibit protective immunity to L. sigmodontis, either through or
alongside CD4CD25 Treg cells, we treated L. sigmodontis-in-
fected BALB/c mice with a neutralizing anti-CTLA-4 Ab alone or
in combination with a depleting anti-CD25 Ab. We have previ-
ously shown that anti-CD25 treatment alone does not affect para-
site recovery (16), and due to restrictions in parasite material this
group was not included. Ab treatments were started 28 days postin-
fection, at the time of the final moult from the L4 to adult stage,
and autopsies were performed at day 60 when infection normally
becomes patent. Although neutralization of CTLA-4 alone had no
effect on parasite recoveries, combined treatment with anti-
FIGURE 2. L. sigmodontis infection induces the proliferation and activation of CD4Foxp3 Treg cells. A, Naive (E) and infected (F) BALB/c mice
were injected with BrdU on day 59 of infection, and on day 60 their PleC were isolated and stained ex vivo for CD4, Foxp3, and BrdU. Results are expressed
as the percentage of BrdU cells within the CD4Foxp3 and CD4Foxp3 populations. Shown are pooled data from four independent experiments.
Symbols denote individual mice and lines represent the mean value (, the percentage of cells incorporating BrdU was significantly different between
Foxp3 and Foxp3 cells independent of infection status (p  0.01) and between naive and infected mice independent of Foxp3 expression (p  0.01;
GLM)). B, Pleural exudate cells from naive (E) and infected (F) were isolated 60 days postinfection and FC was used to determine the geometric mean
fluorescence intensity of Foxp3, CD25, GITR, and CTLA-4 expression on CD4Foxp3 T cells. Symbols denote individual mice and lines represent the
median values (, p  0.05; Wilcoxon rank test). Results are representative of at least two independent experiments. C, CD4 and CD4CD25 T cells
were purified from the pleural cavity of L. sigmodontis-infected mice 60 days postinfection and their proliferative responses were measured in vitro
following restimulation with medium alone () and LsAg (f). Cultures were performed using cells pooled from at least five mice. Shown are mean and
SD of triplicate cultures. Results are representative of two independent experiments.
FIGURE 3. Neutralization of CTLA-4 in combination with CD25 de-
pletion enhances parasite killing. L. sigmodontis-infected mice were treated
with anti-CTLA-4 alone (), anti-CTLA-4 and anti-CD25 (F, E), or con-
trols treated with rat IgG (f, ). Anti-CTLA-4 was given on days 28 and
35 and anti-CD25 on day 28. Adult worm recoveries were assessed 60 days
postinfection. Open and closed symbols, Two independent experiments.
Symbols denote individual mice and lines represent median values (, p 
0.01 between IgG and anti-CTLA-4/CD25-cotreated group; GLM).
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CTLA-4 and anti-CD25 significantly reduced adult parasite burden
by 54% (Fig. 3). Despite the reduction in the number of adult
worms, treatment had no detectable effect on the development of
the surviving parasites, because there were no differences in
growth, uterine embryogenesis, or the proportion of adult females
with uterine Mf (data not shown). Treatment also had no affect on
the prevalence of patent infections, because the percentage of mice
with blood Mf was equivalent between groups (data not shown).
Overall, this suggests that CTLA-4 and CD25 Treg cells syner-
gize to inhibit protective immunity since parasite killing could
only be promoted by neutralizing both suppressive components.
Enhanced parasite killing is not associated with increased
cellular immune responsiveness
Previously, we have shown that the killing of L. sigmodontis adult
parasites by combined anti-GITR and anti-CD25 treatments is as-
sociated with a long-term increase in Ag-specific immune respon-
siveness (16). To determine whether the increased parasite killing
caused by anti-CTLA and anti-CD25 cotreatment was associated
with a similar restoration of immune responsiveness, we measured
the in vitro Ag-specific proliferative and cytokine responses of tLN
cells following treatment. Neither anti-CTLA-4 treatment alone or
in combination with anti-CD25 resulted in increased Ag-specific
production of IL-5 (Fig. 4A) or of IL-4, IL-10, or IFN- (data not
shown). Similarly, there was no increase in Ag-specific prolifera-
tion following a single treatment with CTLA-4 or cotreatment with
anti-CD25 and anti-CTLA-4 (Fig. 4B). Because in vitro assays
may not always reflect in vivo responses, BrdU incorporation was
used to assess the proliferation of pleCD4Foxp3 or
pleCD4Foxp3 populations in vivo. Treatment failed to affect
the proliferation of either cell population within the pleural cavity
(Fig. 4, C and D) or tLN (data not shown).
Alongside increases in immune responsiveness, combined anti-
CD25 and anti-GITR treatments changed the activation phenotype
of the pleCD4 T cells, resulting in reduced expression of CD25,
CTLA-4, and GITR (16). Interestingly, despite performing a CD25
FIGURE 4. Parasite killing is not associated with in-
creased cytokine or proliferative responses. tLN cells
were isolated from IgG-treated (f, ), anti-CTLA-4-
treated (, ), and anti-CTLA-4/anti-CD25-cotreated
(F, E) mice 60 days postinfection and restimulated in
vitro with medium alone (, , E) and LsAg (f, ,
F). Ag-specific production of IL-5 (A) and proliferation
(B) were measured. Results are representative of two
independent experiments. Symbols denote individual
animals and lines represent the median value. C and D,
Naive (‚) and L. sigmodontis-infected mice (f, F, )
were injected with BrdU on day 59 of infection and FC
was used to assess BrdU incorporation by
pleCD4Foxp3 (C) and pleCD4Foxp3 (D) T cells
on day 60. Infected mice were either treated with control
rat IgG (f, ) or cotreated with anti-CD25 and anti-
CTLA-4 (F, E). Symbols denote individual animals and
lines represent the median values.
FIGURE 5. Treatment with anti-CTLA-4 and anti-
CD25 does not induce a long-term change in the acti-
vation phenotype of the pleCD4 T cells. PleC were
isolated from naive (‚) and infected (f,, F) BALB/c
mice 60 days after infection, and the expression of
CD25 (A), Foxp3 (B), CTLA-4 (C), and GITR (D) by
CD4 T cells was assessed using FC. Infected mice
were either control treated with rat IgG (f), treated with
anti-CTLA-4 alone (), or cotreated with anti-CTLA-4
and anti-CD25 (F). Results are representative of two
independent experiments with the exception of Foxp3
that is based on a single experiment. Symbols denote
individual animals and lines represent median values.
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depletion in combination with the CTLA-4 neutralization, expres-
sion of CD25 and Foxp3 by pleCD4 T cells was unchanged at
day 60, suggesting that the Foxp3 Treg cell response had recov-
ered by the time of autopsy (Fig. 5, A and B). The expression of
CTLA-4 and GITR by pleCD4 T cells from anti-CTLA-4 and
anti-CD25-cotreated mice was also unchanged at day 60 of infec-
tion (Fig. 5, C and D). Thus, although cotreatment with anti-
CTLA-4 and anti-CD25 enhanced parasite killing, it did not induce
a long-term change in cellular immune responsiveness or in the
activation phenotype of the pleCD4 T cell population.
CTLA-4 blockade enhances parasite-specific Ab production
independently of CD25 depletion
To test whether the anti-CTLA-4 and anti-CD25 treatments affect
humoral immunity to L. sigmodontis, we measured LsAg-specific
Ab responses at the time of autopsy. L. sigmodontis-specific IgG1,
IgG2a, and IgG2b were detected in infected mice 60 days after
infection, and all three isotype responses were significantly in-
creased following treatment with anti-CTLA-4 alone (Fig. 6).
Combining the anti-CTLA-4 treatment with CD25 depletion did
not further increase parasite-specific isotype responses. L. sigmo-
dontis-infected mice had only low levels of LsAg-specific IgG3,
which were not increased by the Ab treatments (results not shown).
Thus, although there were no detectable increases in cellular im-
mune responses, anti-CTLA-4 treatment alone enhanced L. sigmo-
dontis-specific humoral immunity.
Discussion
The T cell coinhibitory receptor CTLA-4 has been implicated as
one of the mediators of T cell unresponsiveness that is commonly
observed during chronic filarial infections in humans (10, 20). This
hypothesis is strengthened by functional data showing that neu-
tralization of CTLA-4 in vitro can increase the Ag-specific respon-
siveness of human PBMC from patients with lymphatic filariasis
(10, 20). CTLA-4 has also been linked to filarial-induced regula-
tory T cell responses both in humans (20, 44) and in murine in-
fection models (16, 17). We now provide in vivo evidence that
CTLA-4 acts alongside or through CD4CD25 Treg cells to in-
hibit protective immunity to filarial parasites, and that neutraliza-
tion of CTLA-4 in combination with the depletion of
CD4CD25 Treg cells during an established filarial infection
enhances killing of adult filariae.
Two important determinants of susceptibility to L. sigmodontis
infection are the induction of a CD4CD25 Treg cell response
and the development of a hyporesponsive CD4CTLA-
4GITRhigh T cell phenotype at the site of infection (16). Inter-
estingly, despite a role for CD4CD25 Tregs in inhibiting pro-
tective immunity to L. sigmodontis and in controlling Ag-specific
responses to Brugia pahangi (17), L. sigmodontis-induced CD4
T cell hyporesponsiveness does not appear to be linked to direct
suppression by Foxp3 Treg cells, suggesting two independent
levels of T cell regulation (6, 16). In confirmation of this, we have
now demonstrated that the majority of pleCD4CTLA-
4GITRhigh T cells did not express Foxp3 and that removing
CD4Foxp3CD25 Treg cells did not increase the Ag-specific
responsiveness of the pleCD4 T cells. Thus, the Ag-specific hy-
poresponsiveness of the CD4CTLA-4GITRhigh T cell popula-
tion cannot be attributed to ongoing suppression by
CD4Foxp3CD25 Treg cells, and instead suggests that the
CD4CTLA-4GITRhigh T cells predominantly represent a down-
modulated Foxp3 Teff cell population. L. sigmodontis infection
did, however, drive a CD4Foxp3 Treg cell response because the
CD4Foxp3 Treg cells from infected animals showed increased
proliferation in vivo and increased expression of activation mark-
ers compared with naive controls. Similar evidence for multiple
levels of T cell regulation, including Treg cells and Teff cell hy-
poresponsiveness, is seen during chronic human filarial infection
where immune down-regulation is associated both with increases
in Foxp3 mRNA expression and with increases in expression of T
cell anergy factors (10).
The potent inhibitory properties of CTLA-4 make it a prime
candidate for mediating filarial immunosuppression, either acting
directly through CD4CD25CTLA-4 Treg cells (24) or form-
ing an independent suppressive mechanism that may act in con-
junction with CD4 Treg cells (34, 35, 47). Although neutralizing
CTLA-4 alone during an established L. sigmodontis infection did
not promote protective immunity, when CTLA-4 neutralization
was performed in combination with depletion of CD25 Treg
cells, parasite killing was enhanced. CTLA-4 was up-regulated on
CD4Foxp3 T cells and thus could represent a mechanism by
FIGURE 6. Treatment with anti-CTLA-4 increases
L. sigmodontis-specific serum Abs independently of anti-
CD25 treatment. L. sigmodontis-specific IgG1 (A),
IgG2a (B), and IgG2b (C) were quantified in the sera of
naive () and infected animals following treatment with
IgG (f), anti-CTLA-4 (), and anti-CTLA-4 in com-
bination with anti-CD25 (F). Symbols represent indi-
vidual animals and lines represent mean values. Results
are representative of two independent experiments. The
naive and infected IgG groups were compared using
Wilcoxon’s rank test and significant differences between
means (p  0.0125) are indicated by . The three in-
fection and treatment groups were compared using one-
way ANOVA with Tukey’s means comparison. Signif-
icant differences between means are indicated by .
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which CD4 Treg cells inhibit immunity. The greatest increase in
CTLA-4 expression, however, was seen in the CD4Foxp3
population, suggesting a more prominent role on the CD4 Teff
population. If inhibition via CTLA-4 was entirely mediated
through CD4CD25 Treg cells, then either CTLA-4 blockade or
CD25 depletion alone would be expected to be sufficient to induce
protection. Although neither regimen is absolute, the requirement
for both treatments does indicate that they target two independent
mechanisms of suppression. It is likely, therefore, that during L.
sigmodontis infection CTLA-4 has a mode of action independent
to, and synergistic with, CD4CD25 Treg cells. This is similar to
recent work using Schistosoma mansoni infection in which a
CD25 Treg independent role for CTLA-4 was shown (47). De-
spite suggesting a role for CTLA-4 on the CD4 Teff cells, our
results with L. sigmodontis do not rule out a parallel role for
CTLA-4 within the CD4CD25 Treg population.
One possibility is that coinhibition through CTLA-4 is respon-
sible for maintaining the hyporesponsive CD4 T cell phenotype,
since signaling through CTLA-4 can maintain Teff cell anergy (48)
and has been shown to increase the expression of RAP1 and
p27kip1 that are implicated in T cell anergy and inhibition of cell
cycle (49, 50). In human filariasis, T cell unresponsiveness is as-
sociated with increased expression of E3 ubiquitin ligases (c-cbl,
cbl-b, Itch, and Nedd4) that are often up-regulated in anergic T
cells (10). Neutralizing CTLA-4 during in vitro restimulation pre-
vented increases in c-cbl, cbl-b, and Itch and restored Ag respon-
siveness. Thus, CTLA-4 appears to play a major role in controlling
CD4 T cell hyporesponsiveness during filarial infections. In ad-
dition, CTLA-4 may suppress protective immunity by inducing
regulatory DC that inhibit T cell responses through the production
of indoleamine 2,3-dioxygenase (32, 51) or by inducing the ex-
pression of TGF- which is often associated with filarial suppres-
sion (10, 29–31).
The elevated expression of both CTLA-4 and the costimulatory
receptor GITR on the hyporesponsive CD4 Teff cells suggests
that the net balance of opposing signals received through these two
receptors will control how the CD4 Teff cell responds during L.
sigmodontis infection. Using an agonistic anti-GITR Ab to provide
costimulation during infection promotes protective immunity, but
only when performed in combination with depletion of CD25
Treg cells (16). The similar requirements for two-step treatments
when targeting either GITR or CTLA-4 suggest that both may be
acting through the same mechanism. Thus, although anti-CD25
treatment depletes the Treg cell population, both the anti-CTLA-4
and the anti-GITR treatments may act to restore the function of the
hyporesponsive CD4 Teff cells. In this scenario, neutralizing
CTLA-4 will prevent the CD4 Teff cells from receiving the in-
hibitory signals that make them unresponsive, while providing ad-
ditional costimulation through GITR may allow them to overcome
the effects of coinhibition. Similar requirements for reawaking
“exhausted” or unresponsive CD8 T cells have been demon-
strated during chronic viral infections, where neutralizing the coin-
hibitory receptor PD-1 during lymphocytic choriomeningitis virus
infection recovers CD8 T cell effector function, resulting in de-
creased viral loads (52).
Notably, although cotreatment with anti-CD25 and anti-
CTLA-4 enhanced parasite killing, it did not result in any long-
term change in cellular immunity. Increased parasite-specific Ab
responses were seen following treatment with CTLA-4, but they
were equally elevated in both the anti-CTLA-4 alone and anti-
CTLA-4/anti-CD25-cotreated groups and thus their increase was
not associated with parasite killing. The limited changes seen in
immune responses at autopsy correlates with the fact that surviving
adult parasites were still able to develop into a patent infection.
This contrasts with cotreatment using anti-CD25 and anti-GITR
which showed more effective parasite killing (73% reduction vs
54% with CTLA-4), although the infections for the GITR and
CTLA-4 experiments were performed on different occasions, lim-
iting their direct comparison. Treatment with anti-CD25 in com-
bination with anti-GITR was also associated with increased Ag-
specific cytokine and proliferative responses even though autopsy
was performed 1 mo after treatment (16).
Since both anti-GITR and anti-CTLA-4 treatments resulted in
parasite killing, it is unlikely that the increase in immune respon-
siveness seen following anti-GITR treatments is solely a by-prod-
uct of parasite death, suggesting that targeting GITR is a more
potent approach for inducing protective immunity than targeting
CTLA-4. A possible explanation is the differing modes of action of
the anti-CTLA-4 and anti-GITR Abs. While anti-GITR is an ag-
onistic Ab and will actively provide a positive signal to the T cell,
anti-CTLA-4 Ab is a neutralizing Ab and will only result in a
temporary block in CTLA-4 signaling. Given the reported life span
of the anti-CTLA-4 Ab in the blood (43), our treatment regimen
would have blocked CTLA-4 activity for approximately a 2-wk
period. The CD25 depletion is also only temporary and when de-
pleted during infection Foxp3 Treg cells are found to recover
more rapidly than in naive mice (53). Treatment may, therefore,
have resulted in a temporary recovery in immune responsiveness
sufficient to enhance parasite killing and Ab production. As the
CTLA-4 blockade waned and the CD4CD25Foxp3 Treg pop-
ulation recovered, however, the immunosuppressive mechanisms
would reassert themselves, turning cellular immunity off. The in-
creased Ab response may be partly explained by their relatively
long half-life within the blood, meaning that a temporary boost to
the B cell response would still be detectable at day 60. Thus, for
CTLA-4 blockade to be effective, it may need to be maintained
until the infection has been completely cleared. In contrast, pro-
viding an agonistic signal through GITR may result in a long-term
phenotype change in the Teff cell population permanently over-
coming hyporesponsiveness. Certainly, the pleCD4 T cells
showed a change in activation phenotype following anti-CD25/
GITR treatment, including decreased expression of CTLA-4 that
was not seen following anti-CD25/CTLA-4 treatment.
One important question is whether the regulatory mechanisms
seen during L. sigmodontis infection are induced by the parasite to
potentiate its own survival or whether they represent a natural
response to chronic immune challenge. Both CTLA-4 and
CD4Foxp3 Treg cells regulate immune responses to many dif-
ferent infectious agents (41, 54–58) and serve to protect the host
from pathology caused by excessive immune responses (19, 59,
60). It is unlikely therefore that the CTLA-4 and CD4CD25
Treg cell responses are exclusively induced by L. sigmodontis to
inhibit protective immunity, and as neutralizing their activity re-
sulted in parasite killing they cannot be solely involved in con-
trolling immune pathology. The trade-off to mounting a strong
immune response to clear an infection is the induction of immune
pathology. If the cost of clearing an infectious agent is high com-
pared with the cost of the infection itself, then it may be more
beneficial to the host to prevent immune pathology by down-reg-
ulating its own protective immune responses and accept the con-
sequences of a persistent infection (55, 56). Thus, it is possible that
the immune-regulation observed during L. sigmodontis infection is
entirely provoked by the host, rather than representing immune
manipulation by the parasite. Alternatively, the parasite may ex-
ploit the regulatory responses that the host uses to limit pathology
while clearing infection, resulting in an inappropriate bias toward
immune regulation. Distinguishing these two scenarios will be
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important in the treatment of human infections where disrupting im-
mune regulation may have serious consequences in terms of immune
pathology.
Overall, the T cell coinhibitory receptor CTLA-4 and CD25
Treg cells appear to play complementary roles in suppressing
protective immunity to filarial parasites, with CTLA-4 poten-
tially responsible for maintaining hyporesponsiveness within
the CD4 Teff cell compartment. Although it is possible to
enhance protective immunity to an established infection, treat-
ments are only effective if they simultaneously target both lev-
els of T cell regulation. The CTLA-4 signaling pathway there-
fore provides a potential therapeutic target for inducing
protective immunity to filarial parasites.
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